Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6841147

Title:Stem cell factor compositions
Inventors:Zsebo, Krisztina M.; Thousand Oaks, CA, USA
Bosselman, Robert A.; Thousand Oaks, CA, USA
Suggs, Sidney V.; Newbury Park, CA, USA
Martin, Francis H.; Thousand Oaks, CA, USA
Summary:This invention relates to methods of treating blood cell disorders. Described herein are novel non-natural stem cell factors, related nucleic acids and antibodies. The new stem cell factors, the oligonucleotides encoding the factors, methods of production, and associated adequate pharmaceutical compositions are disclosed. Therapeutic applications are included, such as in the treatment of leucopenia or immune deficiency.
Abstract:Novel stem cell factors, oligonucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders involving blood cells are also disclosed.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6841147
Application Number:US1998000224683
Date Filed:31/12/1998
Date Published:11/01/2005
Assignee:Amgen Inc., Thousand Oaks, CA, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/18/2021